Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To present nationally representative data on the lifetime prevalence and comorbidity of 8 specific drug use disorders, separately for abuse and dependence, and mood and anxiety disorders. METHOD: Data come from a representative sample (N=43,093) of the United States civilian, noninstitutional population 18 years and older. Diagnoses of mood, anxiety, and drug use disorders were based upon face-to-face personal interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV). RESULTS: Associations between specific mood and anxiety disorders and specific drug use disorders were virtually all positive and statistically significant (p<.05). In general, associations were greater for dependence than abuse, greater for mood than anxiety disorders, and in some instances stronger among women than men (p<.05). Large odds ratios also were observed for individuals with comorbid mood and anxiety disorders. CONCLUSION: The comorbidity between specific mood and anxiety disorders and specific drug use disorders is pervasive in the U.S. population. Findings suggest that comorbid psychiatric disorders may increase the risk of greater involvement in more serious illicit drug use disorders and that the greater comorbidity between mood and anxiety and drug use disorders among women may reflect greater deviance and psychopathology among drug-using women than men. Findings also suggest that drug abuse prevention and intervention efforts should address other psychiatric conditions. Further, definitions of drug use disorder phenotypes should give careful consideration to other psychiatric conditions as meaningful characteristics of case heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anxiety disorders are highly comorbid with substance use disorders [43]”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [43]
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Conway et al., 2006
In the citing paper
“GAD, PD, agoraphobia, social phobia, and specific phobias are often found to be highly co-morbid with each other as well as other psychiatric disorders including depression, PTSD, and substance-use disorders (Conway et al, 2006;Kaufman and Charney, 2000;Regier et al, 1998).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Conway et al, 2006
In the citing paper
“Furthermore, gambling disorder frequently co-occurs with substance use disorders, particularly alcohol and nicotine, as well as mood and anxiety disorders (Conway, Compton, Stinson, & Grant, 2006; B. F. Grant et al., 2004b; Petry et al., 2005; Ronzitti, Kraus, Hoff, & Potenza, 2018).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Conway, Compton, Stinson, & Grant, 2006
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Self-citationHelzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,081
Comorbidity of substance use disorders with mood and anxiety disorders
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., et al. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00076-8 · Cited by 725
Grant, B. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 686
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.361 · Cited by 644
Self-citation
Cited by
Items 501–600 of 933
Cannabis and Anxiety: a Biopsychosocial Model
Walukevich‐Dienst, K., Crapanzano, K. A., Lewis, E. M., & Buckner, J. D. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00284-w · Cited by 12
Mackesy‐Amiti, M. E., & Donenberg, G. R. (2020) · Psychology of Addictive Behaviors · doi:10.1037/adb0000577 · Cited by 17
Evaluating alcohol demand, craving, and depressive symptoms among women in alcohol treatment
Meshesha, L. Z., Aston, E. R., Teeters, J. B., Blevins, C. E., Battle, C. L., Marsh, E. L., Feltus, S. R., Stein, M. D., & Abrantes, A. M. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106475 · Cited by 14
“Additionally, women with AUD exhibit higher rates of psychiatric comorbidity (Conway et al., 2006; Goldstein et al., 2012), particularly depressive and anxiety disorders (Khan et al.”
BackgroundClark, A. E., Goodwin, S. R., Marks, R. M., Belcher, A. M., Heinlein, E., Bennett, M. E., & Roche, D. J. O. (2021) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.1965407 · Cited by 13
“In past NESARC samples, between 4 and 6% of individuals with panic disorder report lifetime OUD (Conway et al., 2006).”
BackgroundInfluentialMiller, M. W., Reardon, A. F., Wolf, E. J., Prince, L. B., & Hein, C. L. (2013) · Journal of Traumatic Stress · doi:10.1002/jts.21773 · Cited by 10
Helseth, V., Samet, S., Johnsen, J. T., Bramness, J. G., & Waal, H. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.749142 · Cited by 12
Levels of Teen Dating Violence and Substance Use in an Urban Emergency Department
Mason, M. J., Campbell, L. F., Zaharakis, N. M., Foster, R. L., & Richards, S. (2014) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000095 · Cited by 16
Spécificités des problèmes d'utilisation de substances chez les femmes
Barrault, M. (2014) · Psychotropes · doi:10.3917/psyt.193.0009 · Cited by 17
Sallaup, T., Vaaler, A. E., Iversen, V. C., & Güzey, I. C. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1124-y · Cited by 14
Prevalence and social determinants of psychological distress among people who use drugs in Cambodia
Saing, C. H., Prem, K., Uk, P., Chann, N., Chhoun, P., Mun, P., Tuot, S., & Yi, S. (2020) · International Journal of Mental Health Systems · doi:10.1186/s13033-020-00411-5 · Cited by 12
The Anachronical Structure of Herodotus' Histories
de Jong, I. J. F. (2001) · UvA-DARE (University of Amsterdam) · Cited by 10
Bares, C. B., & Andrade, F. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.01.016 · Cited by 12
Aharonovich, E., Scodes, J. M., Wall, M. M., & Hasin, D. S. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108933 · Cited by 15
Fang, S., Hung, C., Huang, C.-Y., Huang, S., & Shao, Y. J. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01025-x · Cited by 10
“…1996), responses to substance-related cues (Potenza et al., 2012; Seo et al., 2011; Volkow et al., 2011), impulsivity, psychiatric comorbidities (Conway et al., 2006; Khan et al., 2013), disease progression (Hernandez-Avila et al., 2004), SUD-related functional impairment (Wu et al., 2010),…”
The Prevalence of Comorbidities and Substance Use Disorder
Kress, C. B., & Schlesinger, S. (2023) · Nursing Clinics of North America · doi:10.1016/j.cnur.2023.02.007 · Cited by 13
The genetic architecture of substance use and its diverse correlations with mental health traits
Wormington, B., Thorp, J. G., Gerring, Z. F., Scott, J. G., Akóṣílè, W., & Derks, E. M. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116200 · Cited by 10
López-Lazcano, A., López‐Pelayo, H., Balcells‐Oliveró, M., Segura, L., & Solé, A. G. (2021) · Adicciones · doi:10.20882/adicciones.1496 · Cited by 12
237 Psychiatric comorbidity in prurigo nodularis and the impact of socioeconomic status
Han, J., Palomino, A., Estupiñan, B., Wozniak, A. W., & Swan, J. W. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.02.259 · Cited by 9
Jones, S. A., Giacco, A. C. D., Barnes, S. J., & Nagel, B. J. (2022) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.22-00143 · Cited by 10
Comparison of Substance Use Milestones in Cannabis- and Cocaine-Dependent Patients
Horey, J. T., Mariani, J. J., Cheng, W. Y., Bisaga, A. M., Sullivan, M. A., Nunes, E. V., & LEVIN, F. R. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.642753 · Cited by 10
“0% lifetime prevalence for marijuana and cocaine dependence 6 – 7 , respectively.”
Substance abuse versus dependence and the structure of common mental disorders
Katz, L. Y., Cox, B. J., Clara, I. P., Oleski, J., & Sacevich, T. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.12.001 · Cited by 10
“In the United States, 10% of adults have been found to have a current substance use disorder [3,7].”
BackgroundLeal, E. M., Delgado, P. G. G., Mann, R., Strıke, C., Brands, B., & Khenti, A. (2012) · Texto & Contexto - Enfermagem · doi:10.1590/s0104-07072012000500013 · Cited by 9
Lifetime mood, anxiety, and drug use disorders are common in the United States population
Bolton, J. M., & Sareen, J. (2006) · Evidence-Based Mental Health · doi:10.1136/ebmh.9.4.113 · Cited by 9
Katzman, M. A., Anand, L., Furtado, M., & Chokka, P. R. (2014) · Psychiatry Research · doi:10.1016/s0165-1781(14)70002-2 · Cited by 10
Balhara, Y. P. S., Sarkar, S., Bera, S. C., Gupta, R. G., Chawla, N., & Lal, R. (2016) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.32501 · Cited by 9
“Substance use disorders (SUD) often tend to co-occur with other psychiatric disorders (1-3).”
BackgroundDesrosiers, A., Blokhina, E. A., Krupitsky, E. M., Zvartau, E. E., Schottenfeld, R. S., & Chawarski, M. C. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.12.007 · Cited by 11
“…symptoms have been associated with risky injection practices (Mackesy-Amiti et al., 2014; Metch et al., 2007) and worse drug treatment outcomes (Conway et al., 2006; Compton et al., 2003), investigating psychiatric symptom presentations in this population is important because symptom severity…”
BackgroundGrubb, L. K. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.07.019 · Cited by 11
Gender differences in psychoactive substance use among undergraduates in a developing country
Aguocha, C., Duru, C. B., Ndukuba, A. C., & Nwefoh, E. C. (2020) · Journal of Substance Use · doi:10.1080/14659891.2020.1779363 · Cited by 13
Tsai, D.-H., Foster, S., Gmel, G. E., & Mohler‐Kuo, M. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106510 · Cited by 10
Willi, J., Süss, H., Grub, J., & Ehlert, U. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.062 · Cited by 13
Núñez, N. A., Joseph, B., Pahwa, M., Seshadri, A., Prokop, L. J., Kung, S., Schak, K. M., Voort, J. L. V., Frye, M. A., & Singh, B. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4376 · Cited by 11
Sugarman, D. E., Meyer, L. E., Reilly, M. E., Rauch, S. L., & Greenfield, S. F. (2021) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.1940412 · Cited by 9
López-Toro, E., Wolf, C. J. H., González, R. A., van den Brink, W., Schellekens, A., Vélez‐Pastrana, M. C., & on behalf of the AFP Working Collaborative Group (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102883 · Cited by 12
“For example, anxiety disorders [5,6] and mood disorders [5,7,8] occur in about 30% and 41% of people with SUD, respectively.”
BackgroundThe pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder
Grunze, H., & Soyka, M. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2083500 · Cited by 12
“The comorbidity between SUD (especially AUD and cannabis use disorder (CUD)) and BD is extremely common with about half of the patients affected [4,5,62–64], and higher as for other mental disorders such as anxiety or depressive disorders [65].”
BackgroundA network approach to substance use, internalizing, and externalizing comorbidity in U.S. adults
Blondino, C., & Prom‐Wormley, E. C. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107421 · Cited by 10
Stam, M. T., Ford‐Gilboe, M., & Regan, S. (2014) · Health Care For Women International · doi:10.1080/07399332.2014.909431 · Cited by 13
Fleury, G., Milin, R., Crockford, D. N., Buckley, L., Charney, D. A., George, T. P., & el‐Guebaly, N. (2015) · PubMed Central · Cited by 9
Virtanen, S., Lagerberg, T., Khemiri, L., Suvisaari, J., Larsson, H., Lichtenstein, P., Chang, Z., & Latvala, A. (2021) · Addiction · doi:10.1111/add.15625 · Cited by 10
Swain, J. E., & Ho, S.-H. S. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.770093 · Cited by 8
“, 2019) risking child maltreatment and costly foster care utilization (Conway et al., 2006).”
BackgroundGarrison‐Desany, H. M., Meyers, J. L., Linnstaedt, S. D., House, S. L., Beaudoin, F. L., An, X., Zeng, D., Neylan, T. C., Clifford, G. D., Jovanović, T., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1249382 · Cited by 13
Komorbide Substanzstörungen in der erwachsenen Allgemeinbevölkerung
Piontek, D., Kraus, L., de Matos, E. G., & Pabst, A. (2013) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911.a000277 · Cited by 9
Cabé, J., Brousse, G., Pereira, B., Cabé, N., Karsinti, E., Zerdazi, E., Icick, R., Llorca, P., Bloch, V., Vorspan, F., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.775670 · Cited by 12
Medenblik, A. M., Garner, A. R., Basting, E. J., Sullivan, J. A., Jensen, M. C., Shorey, R. C., & Stuart, G. L. (2024) · Journal of Clinical Psychology · doi:10.1002/jclp.23692 · Cited by 13
Lawson, W. B., & Lawson, A. (2012) · Springer eBooks · doi:10.1007/978-90-481-8921-2_4 · Cited by 10
Drunk, dangerous and delusional: how legal concept‐creep risks overcriminalization
Crombag, H. S., Child, J. J., & Sullivan, B. (2020) · Addiction · doi:10.1111/add.15024 · Cited by 9
“between SIPs and schizophrenia, or other disorders associated with psychosis such as manicdepression (12,41), they illustrate the potential for co-morbidity and diagnostic uncertainty.”
BackgroundKhobragade, B., Sharma, V., & Deshpande, S. N. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113121 · Cited by 8
Obadeji, A., Oluwole, L. O., Kumolalo, B. F., & Dada, M. U. (2022) · PubMed Central · doi:10.22122/ahj.v14i1.1275 · Cited by 10
Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders
Horigian, V. E., Schmidt, R. D., Shmueli‐Blumberg, D., Hefner, K. R., Feinberg, J., Kondapaka, R., Feaster, D. J., Duan, R., Gonzalez, S. T., Davis, C., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216400 · Cited by 10
“6% having a lifetime history of major depression [8] and between 23 to 42% with lifetime history of PTSD [12].”
BackgroundSubstance Abuse And Mental Health Disorder Among The Youth Living In Conflict Environment
Malla, M. A. (2021) · Journal of Mental Health Issues and Behavior · doi:10.55529/jmhib.11.12.22 · Cited by 11
Dwivedi, I., & Haddad, G. G. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1403326 · Cited by 11
“…memory, and attention) and neuropsychiatric co-morbidities (i.e., anxiety, mood disorders like depression, PTSD, etc.) in animals as well as humans (Brooner et al., 1997; Conway et al., 2006; Farid et al., 2008; Ross et al., 2015; Herlinger and Lingford-Hughes, 2022; Balalian et al., 2023).”
BackgroundLopéz, R. P., Brands, B., Strıke, C., Mann, R., & Khenti, A. (2012) · Texto & Contexto - Enfermagem · doi:10.1590/s0104-07072012000500021 · Cited by 9
“8 Moderadamente disfuncional (4-6) 32 21.”
Diagnostic and Treatment Considerations: Bipolar Patients with Comorbid Substance Use Disorders
Salloum, I. M., Douaihy, A. B., & Williams, L. B. (2008) · Psychiatric Annals · doi:10.3928/00485713-20081101-09 · Cited by 8
Mothers on Methadone: Care in the NICU
Maguire, D. J. (2013) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.32.6.409 · Cited by 11
Kline, A., Callahan, L., Butler, M. J., Hill, L. S., LOSONCZY, M. F., & Smelson, D. A. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260903175882 · Cited by 8
“Major depressive disorder represented the most common diagnosis affecting veterans across all eras served, a finding consistent with previous literature reporting high rates of depression among homeless individuals and among those with substance use disorders ( Nunes, Liu, Samet, Matseoane, & Hasin, 2006 ; Conway, Com…”
Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China
Yang, M., Liao, Y., Wang, Q., Chawarski, M. C., & Hao, W. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.028 · Cited by 10
“Psychiatric disorders and substance use disorders are frequently co-occurring (Compton et al., 2007; Conway et al., 2006; Darke et al., 2007; Grant et al., 2004b; Hasin et al., 2007; Iskandar et al., 2012; Kessler et al., 2005; Regier et al., 1990; Ross et al., 2005; Thirthalli et al., 2012), and…”
BackgroundWhole genome association studies: Deciding when persistence becomes perseveration
Hardy, J., Low, N. C. P., & Singleton, A. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30568 · Cited by 7
“Additionally since psychiatric diseases have great overlap [Kessler et al., 1994; Merikangas et al., 2003; Kessler et al., 2005; Conway et al., 2006], selecting for combinations of comorbid psychiatric diseases has also been used in genetic studies with the hope of providing a more refined…”
BackgroundTrombello, J. M., Killian, M., Liao, A., Sanchez, K., Greer, T. L., Walker, R., Grannemann, B. D., Rethorst, C. D., Carmody, T. J., & Trivedi, M. H. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11707 · Cited by 9
“Two versions of the CAST, clinician-rated (CAST-C) and self-rated (CAST-SR), were developed; both versions contain 17 items that measure five broad domains of activating symptoms: (1) anxiety (anxiety, akathisia), (2) panic (panic attacks), (3) insomnia, (4) irritability (irritability, hostility, aggressiveness), and…”
Bayoumi, I., Schultz, S. E., & Glazier, R. H. (2020) · CMAJ Open · doi:10.9778/cmajo.20190153 · Cited by 9
Torres-Galván, S., Flores-López, M., Romero‐Sanchiz, P., Requena-Ocaña, N., Porras-Perales, Ó., Nogueira‐Arjona, R., Mayoral, F., Araos, P. F., Serrano, A., Muga, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93075-1 · Cited by 10
Roberge, P., Houle, J., Provost, J., Coulombe, S., Beaudin, A., Bower, P., Lemyre, F. C., Drapeau, M., Drouin, M., Hudon, C., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03675-4 · Cited by 9
Rappeneau, V., Morel, A., Yacoubi, M. E., Vaugeois, J., Denoroy, L., & Bérod, A. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv022 · Cited by 10
“Additionally, cocaine abusers show a greater lifetime prevalence of depression (Conway et al., 2006).”
BackgroundRosholm, M., & Andersen, H. L. (2010) · SSRN Electronic Journal · doi:10.2139/ssrn.1672026 · Cited by 10
Cullen, B. A., La Flair, L. N., Storr, C. L., Green, K. M., Alvanzo, A. A. H., Mojtabai, R., Pacek, L. R., & Crum, R. M. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31829faa1c · Cited by 7
“Furthermore, the link between these 2 disorders has been well established (Grant et al., 2004; Kessler et al., 2005; Conway et al., 2006), and prior analyses of population-based samples such as the National Co-morbidity Survey have found annual comorbid prevalence estimates of 11.”
BackgroundInfluentialMoldekleiv, C. D., Lundervold, A. J., Solberg, B. S., Engeland, A., Fadnes, L. T., Chalabianloo, F., & Klungsøyr, K. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07305-1 · Cited by 8
Factors Associated with Psychotic and Depressive Symptoms in Methamphetamine Users
Karabulut, S. (2023) · Iranian Journal of Psychiatry · doi:10.18502/ijps.v19i1.14334 · Cited by 10
“Epidemiological data indicate that % 41.6 of stimulant users have a lifetime history of depression (16).”
BackgroundInfluentialSnaychuk, L. A., Dermody, S. S., Tabri, N., Basedow, C. A., & Kim, H. S. A. (2024) · Journal of Behavioral Addictions · doi:10.1556/2006.2024.00035 · Cited by 8
Bertagna, N. B., Holmgren, E. B., Engi, S. A., Ha, L., Cruz, F. C., Albrechet‐Souza, L., & Wills, T. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06693-8 · Cited by 9
“Women are more likely than men to have anxiety and mood conditions, as well as comorbid alcohol/substance abuse disorders (Back et al. 2011; Conway et al. 2006; Kes-sler et al. 2005).”
Burda, K., Kus, K., Ratajczak, P., Czubak, A., Nowakowska, E., Jędrzejewski, Ł., & Sadowski, C. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2013.38 · Cited by 7
“This procedure led to a distinction between the two groups of ethanol-treated animals: (1) rats with a mean intake of ethanol exceeding 50% of their total fluid (.”
BackgroundBrathwaite, R., Mutumba, M., Nannono, S., Ssewamala, F. M., Filiatreau, L. M., & Namatovu, P. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04339-6 · Cited by 7
“Additionally, research shows there is comorbidity between substance use disorders and mental health disorders [87, 88], including among AYLHIV [54, 57, 58, 89 – 91].”
Heil, J., Zajic, S. C., Albertson, E., Brangan, A., Jones, I., Roberts, W. N., Sabia, M., Bodofsky, E. B., Resch, A. M., Rafeq, R., et al. (2021) · BMC Medical Genomics · doi:10.1186/s12920-020-00837-3 · Cited by 9
“major depressive disorder, bipolar disorder, panic disorder) are disproportionately high in OUD populations [26] which suggests a self-medication pathway, with symptoms driving opioid misuse to mitigate emotional pain and heightened physiological arousal [27, 28].”
BackgroundEllingson, J. M., Richmond‐Rakerd, L. S., & Slutske, W. S. (2015) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2015.76.89 · Cited by 7
Gilder, D. A., Gizer, I. R., Lau, P., & Ehlers, C. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000039 · Cited by 8
“In this Native American sample, SD was not associated with having ASPD/CD, which is inconsistent with findings from the NESARC, in which both cocaine and amphetamine dependence were associated with ASPD, though neither was associated with CD considered separately from ASPD (Compton et al., 2005).”
ResultInfluentialAddiction à la cocaïne : un facteur de risque de suicide ?
Petit, A., Reynaud, M., Lejoyeux, M., Coscas, S., & Karila, L. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2011.12.006 · Cited by 13
“Chez les sujets dépendants, 25,3 % avaient des antécédents de manie et 9,3 % des antécédents d’hypomanie [34].”
BackgroundInfluentialDistress Tolerance as a Familial Vulnerability for Distress-Misery Disorders
Macatee, R. J., Correa, K. A., Carrillo, V. L., Berenz, E. C., & Shankman, S. A. (2020) · Behavior Therapy · doi:10.1016/j.beth.2019.12.008 · Cited by 7
“, 2017, 2018 for placement of OC and eating disorders in internalizing spectrum) and substance use disorders (SUDs) are costly, co-occur at high rates, and cause substantial disability (Compton et al., 2007; Conway et al., 2006; Lewinsohn et al., 2004; Grant et al., 2005; Lai et al., 2015).”
BackgroundDepression and Bipolar Disorders in Patients With Alcohol Use Disorders.
Pary, R., Patel, M., & Lippmann, S. (2017) · Europe PMC (PubMed Central) · Cited by 9
Gender Differences in Addiction
LaGrotta, C. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00355-x · Cited by 12
Eklund, L., Gunnarsson, A. B., Jansson, J.-Å., Pooremamali, P., & Eklund, M. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03388-8 · Cited by 7
Personal and Social Consequences of Psychotropic Substance Use: A Population-Based Internet Survey
Ballestar‐Tarín, M. L., Valle, V. I.-D., Cauli, O., & Navarro-Martínez, R. (2022) · Medicina · doi:10.3390/medicina58010065 · Cited by 11
Food Insecurity Among LGBQ+ Veterans
Haigh, S. V., Halladay, C. W., Kauth, M. R., Going, C., & Cohen, A. J. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.42979 · Cited by 8
Gao, Z., Winhusen, T. M., Gorenflo, M. P., Dorney, I., Ghitza, U. E., Kaelber, D. C., & Xu, R. (2024) · Addiction · doi:10.1111/add.16715 · Cited by 8
Gupta, A., Shebl, F. M., Tong, Y., Wagner, K., Bassett, I. V., Page, K., & Winstanley, E. L. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00340-3 · Cited by 6
“National data suggests that women with SUDs are more likely to have co-occurring mood disorders [40].”
BackgroundSun, C., Yang, S., Wang, X., Shao, Y., Huang, X., Qi, H., Zhang, Z., & Su, G. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1388887 · Cited by 9
Morel, C., Parise, L. F., van der Zee, Y. Y., Issler, O., Cai, M., Browne, C. J., Blando, A., LeClair, K. B., Aubry, A., Haynes, S. E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-80767-7 · Cited by 8
Dugmore, L., & Bauweraerts, S. (2021) · Drugs and Alcohol Today · doi:10.1108/dat-06-2020-0036 · Cited by 6
Sex and drug differences in stress, craving and cortisol response to the trier social stress task
Baker, N. L., Neelon, B., Ramakrishnan, V., Brady, K. T., Gray, K. M., Saladin, M. E., Back, S. E., Flanagan, J. C., Guille, C., & McRae‐Clark, A. L. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06163-z · Cited by 9
Efrati, Y., Goldman, K., Levin, K., & Rosca, P. (2022) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-022-00964-1 · Cited by 6
“…differences between men and women in the rates of psychiatric disorders among those with SUDs, with higher rates of depression, anxiety, and specific personality disorders such as avoidant, dependent, and paranoid disorders in women as compared with men (Conway et al., 2006; Khan et al., 2013).”
Alcohol and opiate misuse in adults with cystic fibrosis
Richards, C. J., Friedman, D., Pinsky, H. T., Gootkind, E., Lee, H., Yonker, L. M., & Georgiopoulos, A. M. (2023) · Pediatric Pulmonology · doi:10.1002/ppul.26541 · Cited by 6
“9% of patients with anxiety or depression have been found to have co‐morbid substance use disorders.(12,13)”
BackgroundInvisible Barriers to Employment: Mental and Behavioral Health Problems
Sano, Y., Richards, L. N., & Lee, J. (2011) · International series on consumer science · doi:10.1007/978-1-4614-0382-1_6 · Cited by 10
Le trouble bipolaire chez l’enfant et l’adolescent : un diagnostic difficile
Geoffroy, P. A., Jardri, R., Étain, B., Thomas, P., & Rolland, B. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.02.025 · Cited by 6
Burda, K., Kus, K., Ratajczak, P., Czubak, A., Hardyk, S., & Nowakowska, E. (2013) · Drug and Chemical Toxicology · doi:10.3109/01480545.2013.851687 · Cited by 6
“EtOH dependence is substantially elevated among individuals with major depression, but also depression rates are increased among EtOH-dependent individuals (Conway et al., 2006; Kessler et al., 1997; Sullivan et al., 2005).”
BackgroundDiagnosing Co-Occurring Substance-Related Disorders
Torres, S. R., & Zayas, L. H. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1104 · Cited by 6
“Conway et al.(4) found that the prevalence of lifetime mood disorders among survey respondents with any drug use disorder was 40.”
BackgroundInfluentialDausey, D. J., Pincus, H. A., Herrell, J. M., & Rickards, L. D. (2007) · Psychiatric Services · doi:10.1176/appi.ps.58.7.903 · Cited by 6
Impaired De Novo Fear Conditioning in Opiate-Dependent Outpatients
Basden, S. L., Orr, S. P., & Otto, M. W. (2016) · Cognitive Therapy and Research · doi:10.1007/s10608-016-9786-9 · Cited by 7
“The rich comorbidity between substance use disorders and anxiety and mood disorders further complications the association between substance use and learning deficits, and may contribute to the persistence of substance use (Conway et al. 2006; Wu and Blazer 2014).”
BackgroundBrain donation at autopsy: clinical characterization and toxicologic analyses
Mighdoll, M. I., & Hyde, T. M. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00011-6 · Cited by 6
Reeves, L. E., Gaudiano, B. A., Metrik, J., Holst, C. G., Morena, A., Sydnor, V. J., Weinstock, L. M., & Epstein-Lubow, G. P. (2018) · Journal of Dual Diagnosis · doi:10.1080/15504263.2018.1470359 · Cited by 6
“…be negative implications resulting from prolonged use, including neuropsychological impairment (Meier et al., 2012), altered brain development (see Volkow, Baler, Compton, & Weiss, 2014 for review), and increased likelihood of psychiatric comorbidities (Agosti et al., 2002; Conway et al., 2006).”
BackgroundVismara, L., Presaghi, F., Bocchia, M., Ricci, R. V., & Ammaniti, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00807 · Cited by 6
Substance Use Disorders: A Biopsychosocial Perspective
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515 · Cited by 11
Wiegersma, S., Hidajat, M., Schrieken, B., Veldkamp, B. P., & Olff, M. (2022) · JMIR Mental Health · doi:10.2196/21111 · Cited by 7
“Substance use disorders are also often found to co-occur with other mental health disorders; for drug use disorders in particular, high associations with anxiety (especially panic disorder) and affective (mood) disorders have been reported [53-55].”
BackgroundVulnerability to PTSD: Psychosocial and Demographic Risk and Resilience Factors
Bar‐Shai, M., & Klein, E. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7522-5_1 · Cited by 9
Management of Substance Abuse in Pregnancy: Maternal and Neonatal Aspects
Brandt, L., Leifheit, A. K., Finnegan, L. P., & Fischer, G. (2014) · Springer eBooks · doi:10.1007/978-3-642-54562-7_12 · Cited by 8
Metadata
- Authors
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 247-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2059057223
- Cited by
- 934
- References
- 24
- Citations by year
- 2026: 25 · 2025: 42 · 2024: 44 · 2023: 35 · 2022: 56 · 2021: 56 · 2020: 83 · 2019: 38 · 2018: 51 · 2017: 55 · 2016: 53 · 2015: 63 · 2014: 55 · 2013: 56 · 2012: 45
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- psychiatric comorbidity, mood disorders, anxiety disorders, drug use disorders, substance dependence, substance abuse, lifetime prevalence, sex differences, DSM-IV, illicit drug use
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Depressive Disorder, Female, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Regression Analysis, Sex Factors, United States, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.